Table of Contents

2019-2024 Global Oncology Based Molecular Diagnostics Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oncology Based Molecular Diagnostics Consumption 2014-2024
2.1.2 Oncology Based Molecular Diagnostics Consumption CAGR by Region
2.2 Oncology Based Molecular Diagnostics Segment by Type
2.2.1 PCR
2.2.2 Multiplex PCR
2.2.3 In Situ Hybridization
2.2.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
2.3 Oncology Based Molecular Diagnostics Consumption by Type
2.3.1 Global Oncology Based Molecular Diagnostics Consumption Market Share by Type (2014-2019)
2.3.2 Global Oncology Based Molecular Diagnostics Revenue and Market Share by Type (2014-2019)
2.3.3 Global Oncology Based Molecular Diagnostics Sale Price by Type (2014-2019)
2.4 Oncology Based Molecular Diagnostics Segment by Application
2.4.1 Breast Cancer
2.4.2 Prostate Cancer
2.4.3 Colorectal Cancer
2.4.4 Cervical Cancer
2.4.5 Other
2.5 Oncology Based Molecular Diagnostics Consumption by Application
2.5.1 Global Oncology Based Molecular Diagnostics Consumption Market Share by Application (2014-2019)
2.5.2 Global Oncology Based Molecular Diagnostics Value and Market Share by Application (2014-2019)
2.5.3 Global Oncology Based Molecular Diagnostics Sale Price by Application (2014-2019)

3 Global Oncology Based Molecular Diagnostics by Players
3.1 Global Oncology Based Molecular Diagnostics Sales Market Share by Players
3.1.1 Global Oncology Based Molecular Diagnostics Sales by Players (2017-2019)
3.1.2 Global Oncology Based Molecular Diagnostics Sales Market Share by Players (2017-2019)
3.2 Global Oncology Based Molecular Diagnostics Revenue Market Share by Players
3.2.1 Global Oncology Based Molecular Diagnostics Revenue by Players (2017-2019)
3.2.2 Global Oncology Based Molecular Diagnostics Revenue Market Share by Players (2017-2019)
3.3 Global Oncology Based Molecular Diagnostics Sale Price by Players
3.4 Global Oncology Based Molecular Diagnostics Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Oncology Based Molecular Diagnostics Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Oncology Based Molecular Diagnostics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Oncology Based Molecular Diagnostics by Regions
4.1 Oncology Based Molecular Diagnostics by Regions
4.1.1 Global Oncology Based Molecular Diagnostics Consumption by Regions
4.1.2 Global Oncology Based Molecular Diagnostics Value by Regions
4.2 Americas Oncology Based Molecular Diagnostics Consumption Growth
4.3 APAC Oncology Based Molecular Diagnostics Consumption Growth
4.4 Europe Oncology Based Molecular Diagnostics Consumption Growth
4.5 Middle East & Africa Oncology Based Molecular Diagnostics Consumption Growth

5 Americas
5.1 Americas Oncology Based Molecular Diagnostics Consumption by Countries
5.1.1 Americas Oncology Based Molecular Diagnostics Consumption by Countries (2014-2019)
5.1.2 Americas Oncology Based Molecular Diagnostics Value by Countries (2014-2019)
5.2 Americas Oncology Based Molecular Diagnostics Consumption by Type
5.3 Americas Oncology Based Molecular Diagnostics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Oncology Based Molecular Diagnostics Consumption by Countries
6.1.1 APAC Oncology Based Molecular Diagnostics Consumption by Countries (2014-2019)
6.1.2 APAC Oncology Based Molecular Diagnostics Value by Countries (2014-2019)
6.2 APAC Oncology Based Molecular Diagnostics Consumption by Type
6.3 APAC Oncology Based Molecular Diagnostics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Oncology Based Molecular Diagnostics by Countries
7.1.1 Europe Oncology Based Molecular Diagnostics Consumption by Countries (2014-2019)
7.1.2 Europe Oncology Based Molecular Diagnostics Value by Countries (2014-2019)
7.2 Europe Oncology Based Molecular Diagnostics Consumption by Type
7.3 Europe Oncology Based Molecular Diagnostics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Oncology Based Molecular Diagnostics by Countries
8.1.1 Middle East & Africa Oncology Based Molecular Diagnostics Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Oncology Based Molecular Diagnostics Value by Countries (2014-2019)
8.2 Middle East & Africa Oncology Based Molecular Diagnostics Consumption by Type
8.3 Middle East & Africa Oncology Based Molecular Diagnostics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Oncology Based Molecular Diagnostics Distributors
10.3 Oncology Based Molecular Diagnostics Customer

11 Global Oncology Based Molecular Diagnostics Market Forecast
11.1 Global Oncology Based Molecular Diagnostics Consumption Forecast (2019-2024)
11.2 Global Oncology Based Molecular Diagnostics Forecast by Regions
11.2.1 Global Oncology Based Molecular Diagnostics Forecast by Regions (2019-2024)
11.2.2 Global Oncology Based Molecular Diagnostics Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Oncology Based Molecular Diagnostics Forecast by Type
11.8 Global Oncology Based Molecular Diagnostics Forecast by Application

12 Key Players Analysis
12.1 Abbott Laboratories
12.1.1 Company Details
12.1.2 Oncology Based Molecular Diagnostics Product Offered
12.1.3 Abbott Laboratories Oncology Based Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Abbott Laboratories News
12.2 Bayer Healthcare
12.2.1 Company Details
12.2.2 Oncology Based Molecular Diagnostics Product Offered
12.2.3 Bayer Healthcare Oncology Based Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Bayer Healthcare News
12.3 Becton Dickinson
12.3.1 Company Details
12.3.2 Oncology Based Molecular Diagnostics Product Offered
12.3.3 Becton Dickinson Oncology Based Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Becton Dickinson News
12.4 Cepheid
12.4.1 Company Details
12.4.2 Oncology Based Molecular Diagnostics Product Offered
12.4.3 Cepheid Oncology Based Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Cepheid News
12.5 Dako
12.5.1 Company Details
12.5.2 Oncology Based Molecular Diagnostics Product Offered
12.5.3 Dako Oncology Based Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Dako News
12.6 Danaher Corporation
12.6.1 Company Details
12.6.2 Oncology Based Molecular Diagnostics Product Offered
12.6.3 Danaher Corporation Oncology Based Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Danaher Corporation News
12.7 Gen Probe(Hologic)
12.7.1 Company Details
12.7.2 Oncology Based Molecular Diagnostics Product Offered
12.7.3 Gen Probe(Hologic) Oncology Based Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Gen Probe(Hologic) News
12.8 Roche Diagnostics
12.8.1 Company Details
12.8.2 Oncology Based Molecular Diagnostics Product Offered
12.8.3 Roche Diagnostics Oncology Based Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Roche Diagnostics News
12.9 Siemens Healthcare
12.9.1 Company Details
12.9.2 Oncology Based Molecular Diagnostics Product Offered
12.9.3 Siemens Healthcare Oncology Based Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Siemens Healthcare News

13 Research Findings and Conclusion